Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04942886 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 14 wordsv5
  2. Lead sponsor: Dong-Gun Lee to Seoul St. Mary's Hospitalv4 Show 5 more changesShow less
    • Primary and study completion dates: Dec 31, 2025 to Dec 31, 2028
    • Enrollment target: 164 to 226
    • Interventions: Entecavir (Drug) to Baracle Tab.® (Drug)
    • Eligibility criteria expanded, about 32 words
    • Study description expanded, about 2 words
  3. Trial status: Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Jul 25, 2021 to Aug 21, 2021
    • Site details revised
    v3
  4. Start date: Jul 1, 2021 to Jul 25, 2021
    • Study description expanded, about 37 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a randomized, prospective, comparative study of the effectiveness of prophylactic entecavir treatment for HBV reactivation in past HBV infected patients (HBsAg-, HBcIgG+) with allogeneic hematopoietic stem cell transplantation.
Trial Details
NCT Number NCT04942886
Lead Sponsor Seoul St. Mary's Hospital
Conditions
(from sponsor)		 Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug, HBV
Enrollment 226 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov